Long-term outcomes after blinatumomab treatment for ALL

Government failure to provide vaccination services and radiation facilities is unacceptable

How is cancer-related venous thromboembolism treated in real world practice?

Obesity provides a fertile ground for cancer to grow

Dalteparin thromboprophylaxis for cancer patients at high risk of venous thromboembolism

Chemoprevention in breast cancer and possible vaccine for prostate cancer

Response to rituximab induction is a predictive biomarker in post-transplant lymphoproliferative disorder

“Low but real” risk of myelodysplastic syndromes caused by thyroid cancer treatment

High dose chemotherapy plus transplant remains standard care for young newly diagnosed multiple myeloma patients

ENDEAVOR: carfilzomib new standard in multiple myeloma?

How can functional drug screening guide personalised cancer therapy?

How do genes influence the development of chronic idiopathic thrombocytopenic purpura?